Raymond James analyst Jayson Bedford raised the price target on Edwards Lifesciences (NYSE: EW) to $186.00 (from $175.00) while maintaining a Outperform rating.

Analyst PT Change

Edwards Lifesciences (EW) PT Raised to $190 at Canaccord GenuityFebruary 1, 2019 7:29 AM Edwards Lifesciences (EW) PT Raised to $190 at BMO CapitalFebruary 1, 2019 7:23 AM Edwards Lifesciences (EW) PT Raised to $175 at UBSFebruary 1, 2019 7:15 AM Edwards Lifesciences (EW) PT Raised to $182 at RBC CapitalFebruary 1, 2019 6:42 AM Form 8-K Edwards Lifesciences For: Jan 31January 31, 2019 4:26 PM Edwards Lifesciences (EW) Reports In-Line Q4 EPS, Q1 EPS Guidance Comes in LightJanuary 31, 2019 4:19 PM Edwards Lifesciences Reports Fourth Quarter ResultsJanuary 31, 2019 4:15 PM